SAM #75N98026Q00655

NIH Sole-Source Procurement of Illumina NextSeq2000 Sequencer

The National Institutes of Health (NIH), Office of Logistics and Operations (OLAO), Hospital and Laboratory Support Division, is planning a sole-source procurement for a NextSeq2000 sequencer. - Government Buyer: - National Institutes of Health (NIH) - Office of Logistics and Operations (OLAO) - Hospital and Laboratory Support Division - OEM and Vendor: - Illumina, Inc. (OEM and sole vendor specified) - Product Requested: - NextSeq2000 sequencer - No specific part number or quantity provided - Purpose and Requirements: - Supports the NHGRI Microarrays and Single-cell Genomics Core (MSCGC) - Enables genomics and transcriptomics services for NIH investigators - Brand-name justification: Only Illumina, Inc. is considered capable of meeting the requirement - Notable Details: - Sole-source, non-competitive procurement - Opportunity for other vendors to submit capability statements if they can meet the requirement - Procurement under NAICS code 811210 and FAR Part 13 Simplified Acquisition Procedures

Description

General Information

Document Type:

Presolicitation

Synopsis Number:

75N98026Q00655

Posted Date:

June 17, 2026

Original Response Date:

June 29, 2026

Current Response Date:

June 29, 2026

Set Aside:

N/A

NAICS Code:

811210

Contracting Office Address

National Institutes of Health (NIH), Office of the Director (OD)

Office of Logistics and Operations (OLAO)

Office of Acquisition and Logistics Management (OALM)

Hospital and Laboratory Support Division

6701 Rockledge Drive

Bethesda, MD 20817 

Description

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:

Illumina, Inc

5200 Illumina Way

San Diego CA 92122-4616

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 811210 with a Size Standard $34M.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

GENERAL INFORMATION

Title: NextSeq2000 sequencer Background Information: The NHGRI Microarrays and Single-cell Genomics Core (MSCGC) was established on 2000. The facility represents a consortium between the National Human Genome Research Institute (NHGRI), the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS). It has been providing intramural investigators with full service, cost-effective and time-efficient access to comprehensive state-of-the-art genomics and transcriptomics technologies for understanding genome copy number, patterns of gene expression, microRNA profiles and epigenetics. Most investigator project requests are “Full Service”, in which the investigator will provide the chips, labeling kit and isolated RNA/DNA samples, and the core performs labeling, hybridization and data extraction. Upon project completion, the investigator is then provided with a summary report including the data quality assessment, preliminary analysis and raw data output files. Since its conception, the core has processed tens of thousands RNA/DNA samples thus building experience and expertise in bringing accuracy and consistency to our genomics services through rigorous standardization of protocols and multiple quality control checks..

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by June 29, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00655. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”

View original listing